743 related articles for article (PubMed ID: 16028017)
1. Characterization of drug particle surface energetics and young's modulus by atomic force microscopy and inverse gas chromatography.
Davies M; Brindley A; Chen X; Marlow M; Doughty SW; Shrubb I; Roberts CJ
Pharm Res; 2005 Jul; 22(7):1158-66. PubMed ID: 16028017
[TBL] [Abstract][Full Text] [Related]
2. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
Int J Pharm; 2012 Jul; 430(1-2):26-33. PubMed ID: 22449413
[TBL] [Abstract][Full Text] [Related]
3. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Jones MD; Buckton G
Int J Pharm; 2016 Jul; 509(1-2):419-430. PubMed ID: 27265314
[TBL] [Abstract][Full Text] [Related]
5. Surface energy and interparticle forces correlations in model pMDI formulations.
Traini D; Rogueda P; Young P; Price R
Pharm Res; 2005 May; 22(5):816-25. PubMed ID: 15906178
[TBL] [Abstract][Full Text] [Related]
6. A quantitative assessment of inhaled drug particle-pulmonary surfactant interaction by atomic force microscopy.
Davies MJ; Brindley A; Chen X; Doughty SW; Marlow M; Roberts CJ
Colloids Surf B Biointerfaces; 2009 Oct; 73(1):97-102. PubMed ID: 19500951
[TBL] [Abstract][Full Text] [Related]
7. Towards the understanding and prediction of material changes during micronisation using atomic force microscopy.
Perkins MC; Bunker M; James J; Rigby-Singleton S; Ledru J; Madden-Smith C; Luk S; Patel N; Roberts CJ
Eur J Pharm Sci; 2009 Aug; 38(1):1-8. PubMed ID: 19447176
[TBL] [Abstract][Full Text] [Related]
8. Surface energy analysis as a tool to probe the surface energy characteristics of micronized materials--a comparison with inverse gas chromatography.
Gamble JF; Leane M; Olusanmi D; Tobyn M; Supuk E; Khoo J; Naderi M
Int J Pharm; 2012 Jan; 422(1-2):238-44. PubMed ID: 22100516
[TBL] [Abstract][Full Text] [Related]
9. Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug.
Puri V; Shur J; Narang AS
Mol Pharm; 2019 Oct; 16(10):4339-4351. PubMed ID: 31454254
[TBL] [Abstract][Full Text] [Related]
10. Towards screening of inhalation formulations: measuring interactions with atomic force microscopy.
Bunker M; Davies M; Roberts C
Expert Opin Drug Deliv; 2005 Jul; 2(4):613-24. PubMed ID: 16296789
[TBL] [Abstract][Full Text] [Related]
11. Inverse gas chromatography a tool to follow physicochemical modifications of pharmaceutical solids: Crystal habit and particles size surface effects.
Cares-Pacheco MG; Calvet R; Vaca-Medina G; Rouilly A; Espitalier F
Int J Pharm; 2015 Oct; 494(1):113-26. PubMed ID: 26248145
[TBL] [Abstract][Full Text] [Related]
12. The use of atomic force microscopy to study the conditioning of micronised budesonide.
Jones MD; Young PM; Traini D; Shur J; Edge S; Price R
Int J Pharm; 2008 Jun; 357(1-2):314-7. PubMed ID: 18342461
[TBL] [Abstract][Full Text] [Related]
13. Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.
Shur J; Pitchayajittipong C; Rogueda P; Price R
Ther Deliv; 2013 Aug; 4(8):925-37. PubMed ID: 23919472
[TBL] [Abstract][Full Text] [Related]
14. Investigation into the effect of humidity on drug-drug interactions using the atomic force microscope.
Young PM; Price R; Tobyn MJ; Buttrum M; Dey F
J Pharm Sci; 2003 Apr; 92(4):815-22. PubMed ID: 12661066
[TBL] [Abstract][Full Text] [Related]
15. The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approach.
Hooton JC; Jones MD; Harris H; Shur J; Price R
Drug Dev Ind Pharm; 2008 Sep; 34(9):974-83. PubMed ID: 18622874
[TBL] [Abstract][Full Text] [Related]
16. Characterization of particle-interactions by atomic force microscopy: effect of contact area.
Hooton JC; German CS; Allen S; Davies MC; Roberts CJ; Tendler SJ; Williams P
Pharm Res; 2003 Mar; 20(3):508-14. PubMed ID: 12669976
[TBL] [Abstract][Full Text] [Related]
17. Identifying and mapping surface amorphous domains.
Ward S; Perkins M; Zhang J; Roberts CJ; Madden CE; Luk SY; Patel N; Ebbens SJ
Pharm Res; 2005 Jul; 22(7):1195-202. PubMed ID: 16028021
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization of D-mannitol polymorphs: the challenging surface energy determination by inverse gas chromatography in the infinite dilution region.
Cares-Pacheco MG; Vaca-Medina G; Calvet R; Espitalier F; Letourneau JJ; Rouilly A; Rodier E
Int J Pharm; 2014 Nov; 475(1-2):69-81. PubMed ID: 25151549
[TBL] [Abstract][Full Text] [Related]
19. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
Sethuraman VV; Hickey AJ
AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922
[TBL] [Abstract][Full Text] [Related]
20. Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.
Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
Pharm Res; 2012 Apr; 29(4):994-1006. PubMed ID: 22161310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
